Royalty Pharma (RPRX) Reports Q4 Revenue of $594 million
Go back to Royalty Pharma (RPRX) Reports Q4 Revenue of $594 million| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 54.49 +0.92 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.57 | 52 Week High | $3.48 | |||
| Open | $53.58 | 52 Week Low | $0.80 | |||
| Day High | $54.56 | P/E | N/A | |||
| Day Low | $53.31 | EPS | $-1.54 | |||
| Volume | 860,444 | |||||
